Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus)
Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus): Suspected DKA → Confirm DKA Diagnosis → Assess DKA Severity → 1. IV Fluid Resuscitation...
Interactive Decision Tree
Algorithm Steps
- ▶Start
Suspected DKA
Hyperglycemia + Ketosis + Acidosis
- ●Action
Confirm DKA Diagnosis
Check diagnostic criteria
- Glucose: typically >250 mg/dL (may be lower in euglycemic DKA)
- pH <7.3 and/or HCO3 <18 mEq/L
- Ketones: β-hydroxybutyrate >3.0 mmol/L or urine ketones moderate-large
- Anion gap >10-12
- Consider euglycemic DKA if on SGLT2 inhibitor
- ◆Decision
Assess DKA Severity
Mild/Moderate vs Severe
- MILD: pH 7.25-7.30, HCO3 15-18, alert
- MODERATE: pH 7.0-7.24, HCO3 10-14, alert/drowsy
- SEVERE: pH <7.0, HCO3 <10, stupor/coma
- ●Action
1. IV Fluid Resuscitation
Start immediately - do not delay for insulin
- 0.9% NaCl: 1-1.5 L in first hour (15-20 mL/kg)
- Then 250-500 mL/hr based on hydration status
- Switch to 0.45% NaCl if corrected Na+ normal/elevated
- Add D5 when glucose <200 mg/dL
- Typical deficit: 3-6 liters
- ◆Decision
Serum K+ Level?
Check K+ BEFORE starting insulin
- Total body K+ depleted despite serum level
- K+ will drop rapidly with insulin therapy
- ⚠Warning
K+ <3.3 mEq/L
HOLD INSULIN until K+ ≥3.3
- Replace K+ aggressively (20-40 mEq/hr)
- Cardiac monitoring essential
- Recheck K+ every 1-2 hours
- DO NOT give insulin until K+ ≥3.3
- ●Action
2. Insulin Therapy
Start after fluid bolus and K+ assessment
- Regular insulin IV: 0.1 units/kg bolus, then 0.1 units/kg/hr
- OR 0.14 units/kg/hr continuous (no bolus)
- Target glucose drop: 50-70 mg/dL/hr
- If glucose not falling, double rate
- When glucose <200, reduce to 0.02-0.05 units/kg/hr + D5
- ◆Decision
pH <6.9?
Consider bicarbonate only in severe acidosis
- ●Action
Bicarbonate Therapy
For pH <6.9 only (controversial)
- 100 mEq NaHCO3 in 400 mL water + 20 mEq KCl
- Infuse over 2 hours
- Repeat if pH still <7.0
- NOT recommended if pH ≥6.9
- ●Action
Ongoing Monitoring
Frequent labs and clinical assessment
- BMP: every 2-4 hours initially
- Glucose: every 1 hour
- β-hydroxybutyrate: every 2-4 hours (preferred over anion gap)
- Venous pH: every 2-4 hours until stable
- Fluid balance, urine output, mental status
- ●Action
Identify Precipitant
The 5 I's and other causes
- Infection (UTI, pneumonia, skin)
- Infarction (MI, stroke)
- Insulin omission/non-adherence
- Intoxication (alcohol, drugs)
- Infant (pregnancy)
- Also: new-onset T1DM, pancreatitis, meds (steroids, SGLT2i)
- ◆Decision
DKA Resolution?
All criteria must be met
- Glucose <200 mg/dL
- Anion gap <12 OR β-hydroxybutyrate <0.6 mmol/L
- pH ≥7.3 and HCO3 ≥15
- Patient able to eat
- ●Action
Transition to SubQ Insulin
Overlap IV and SubQ by 1-2 hours
- Give basal insulin (glargine/detemir) 1-2 hrs before stopping drip
- Calculate total daily dose based on drip rate
- Resume home regimen if appropriate
- NEW diagnosis: 0.5-0.8 units/kg/day total
- Identify and treat precipitant
- ✓Outcome
DKA Resolved
Continue monitoring, diabetes education
- ●Action
K+ 3.3-5.3 mEq/L
Add K+ to fluids + start insulin
- Add 20-30 mEq KCl per liter of fluid
- Target K+ 4-5 mEq/L
- Monitor K+ every 2-4 hours
- ●Action
K+ >5.3 mEq/L
Hold K+, start insulin, recheck frequently
- Do not add K+ to fluids initially
- K+ will drop with insulin/fluids
- Recheck every 2 hours
- ECG monitoring
- ✓Outcome
Complicated Course
ICU for severe DKA, cerebral edema, ARDS
Guideline Source
Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Scientific Statement From the American Diabetes Association, European Association for the Study of Diabetes, and the Joint British Diabetes Societies
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Fluid rates may need adjustment in elderly, cardiac, or renal disease
- Insulin sensitivity varies - monitor closely and adjust
- Cerebral edema risk in children/young adults - different protocols apply
- Euglycemic DKA (SGLT2i-related) may have normal glucose
- Concurrent HHS may require modified approach
Applicable Regions
EU: EASD concordant; fixed-rate insulin infusion (FRII) used in some centers
UK: JBDS protocol uses FRII at 0.1 units/kg/hr; emphasizes ketone monitoring
US: ADA guidelines; insulin and potassium protocols standard
International: Adapt to local insulin availability; frequent K+ monitoring critical
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus)?
The Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Scientific Statement From the American Diabetes Association, European Association for the Study of Diabetes, and the Joint British Diabetes Societies.
What guideline is the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus) based on?
This algorithm is based on Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Scientific Statement From the American Diabetes Association, European Association for the Study of Diabetes, and the Joint British Diabetes Societies (DOI: 10.2337/dci24-0032).
What are the limitations of the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus)?
Known limitations include: Fluid rates may need adjustment in elderly, cardiac, or renal disease; Insulin sensitivity varies - monitor closely and adjust; Cerebral edema risk in children/young adults - different protocols apply; Euglycemic DKA (SGLT2i-related) may have normal glucose; Concurrent HHS may require modified approach. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free